Parkinson's Disease Trial, Recruiting NCT07299279 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07299279
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 30 and 80 years who have been diagnosed with Parkinson's disease according to recognised medical diagnostic standards, at a mild to moderate stage of the condition (Hoehn & Yahr stage 1 to 3), and who also have a diagnosis of mild cognitive impairment meeting specific clinical criteria
  • People who currently do not exercise more than 120 minutes per week at a moderate level, or more than 60 minutes per week at a vigorous level
  • People who are able to give their own informed consent to take part in the study

Who may not be able to join:

  • People who are pregnant
  • People who have a medical condition that prevents them from doing vigorous physical exercise
  • People who have a cancer diagnosis or an autoimmune condition
  • People who are currently taking medications that affect the immune system or reduce inflammation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Paolo Calabresi, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: +390630154303

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 June 2025
Est. completion
30 April 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Motor performance; non motor assessment; disease stage; Cognitive evaluation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov